Consort Medical plc (CSRT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Consort Medical plc (CSRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12420
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and POC diagnostic devices. The company provides inhaler and auto-injector technologies and manufacturing services to pharmaceutical manufacturers; and active pharmaceutical ingredients (API), and finished dose formulation and manufacturing services. The company offers its products to pharmaceutical companies in the US, Europe, and other parts of the world through its subsidiaries and distributors. Consort Medical is headquartered in Hertfordshire, England, the UK.

Consort Medical plc (CSRT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consort Medical plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9
Consort Medical plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Consort Medical plc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Precision Ocular Raises USD20.5 Million in Series A Financing 11
Precision Ocular Raises USD19.4 Million in Venture Financing 13
Partnerships 15
SteadyMed Therapeutics Enters into Co-Development Agreement with Bespak 15
Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 16
Licensing Agreements 17
Consort Medical Enter into Development Agreement with Opiant Pharma 17
Equity Offering 18
Consort Medical Raises USD160.6 Million in Rights Issue of Shares 18
Acquisition 20
Consort Medical Acquires Aesica Holdco for USD378.5 million 20
Consort Medical plc – Key Competitors 21
Consort Medical plc – Key Employees 22
Consort Medical plc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Jun 14, 2018: Consort Medical delivered another year of good growth in revenue and profit 25
Dec 05, 2017: Consort Medical: Interim results 28
Jun 15, 2017: Consort Medical: Full year results 29
Corporate Communications 30
Nov 06, 2018: Consort Medical announces its board change 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Consort Medical plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consort Medical plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consort Medical plc, Deals By Therapy Area, 2012 to YTD 2018 8
Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9
Consort Medical plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Precision Ocular Raises USD20.5 Million in Series A Financing 11
Precision Ocular Raises USD19.4 Million in Venture Financing 13
SteadyMed Therapeutics Enters into Co-Development Agreement with Bespak 15
Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 16
Consort Medical Enter into Development Agreement with Opiant Pharma 17
Consort Medical Raises USD160.6 Million in Rights Issue of Shares 18
Consort Medical Acquires Aesica Holdco for USD378.5 million 20
Consort Medical plc, Key Competitors 21
Consort Medical plc, Key Employees 22
Consort Medical plc, Other Locations 23
Consort Medical plc, Subsidiaries 23

List of Figures
Consort Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consort Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Consort Medical plc (CSRT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pets at Home Group Plc:戦略・SWOT・企業財務分析
    Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Arca Continental SAB de CV:企業の戦略・SWOT・財務情報
    Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Celina Insurance Group:企業の戦略・SWOT・財務情報
    Celina Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Celina Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Petroleo Brasileiro SA (PETR4)-エネルギー分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • City National Wealth Management:企業の戦略・SWOT・財務情報
    City National Wealth Management - Strategy, SWOT and Corporate Finance Report Summary City National Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Costco Wholesale UK Limited:企業の戦略・SWOT・財務分析
    Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Jellagen Pty Ltd (Jellagen) is a provider of medical grade collagen products. The company’s products offer medical grade collagen supplied in the form of hydragel used in wound dressing, soft tissue regeneration, tissue engineering and haemostats. Its product pipeline offer scaffolds, which …
  • Rubis SCA (RUI):石油・ガス:M&Aディール及び事業提携情報
    Summary Rubis SCA (Rubis) is an independent downstream company that carries out the storage, distribution and trading of bulk petroleum and chemical products. Its product portfolio includes fuel oil, liquefied petroleum gas (LPG), gasoline, diesel, home heating oil, chemical products, edible oils, m …
  • Molecular Templates Inc (MTEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The company’s pipeline products include MT-3724, MT-4019, MT-5111, MT-5050 and MT-6868. Its lead product MT-3724, a fusion …
  • Diehl Defence Holding GmbH:企業の戦略的SWOT分析
    Diehl Defence Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Compania Espanola de Petroleos SAU:企業の戦略的SWOT分析
    Compania Espanola de Petroleos SAU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Nuance Communications, Inc.:企業の戦略・SWOT・財務情報
    Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • United Therapeutics Corp (UTHR):医療機器:M&Aディール及び事業提携情報
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • Citigroup Inc:戦略・SWOT・企業財務分析
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Safran SA:企業の戦略・SWOT・財務情報
    Safran SA - Strategy, SWOT and Corporate Finance Report Summary Safran SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Langley Holdings plc:企業の戦略・SWOT・財務分析
    Langley Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Langley Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務情報
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Swift Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆